Related Experiment Videos

"To B or Not to B"…That Is the Question: Whether We Can Identify Those at Risk for Cardiac Dysfunction During Cancer

Daniel J Lenihan¹

¹Cardiovascular Division, Washington University in St. Louis, St. Louis, Missouri.

JACC. Heart Failure

|November 12, 2018

Abstract

No abstract available in PubMed .

Keywords:

anthracycline cardiotoxicity heart failure stages trastuzumab

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

A call to action: improving access to cardiac MRI for diagnosis of immune checkpoint inhibitor related myocarditis in low and middle income countries.

Cardio-oncology (London, England)·2025

Principles of optimal multidisciplinary management of prostate cancer in clinical practice.

Cardio-oncology (London, England)·2025

SGLT2i and Primary Prevention of Cancer Therapy-Related Cardiac Dysfunction in Patients With Diabetes.

JACC. CardioOncology·2025

Cardioprotective Potential of Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Cancer Treated With Anthracyclines: An Observational Study.

The American journal of cardiology·2024

Incidental Coronary Arterial Calcification for Cardiovascular Risk Assessment in Men With Prostate Cancer Undergoing PET/CT Imaging.

Clinical genitourinary cancer·2024

Clinicopathological classification of immune checkpoint inhibitor-associated myocarditis: possible refinement by measuring macrophage abundance.

Cardio-oncology (London, England)·2023

See all related articles